Results 81 to 90 of about 2,077,783 (311)

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer   +14 more
wiley   +1 more source

Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Clinical trials for Huntington's disease (HD) enrolling persons before clinical motor diagnosis (CMD) lack validated biomarkers. This study aimed to conduct an unbiased discovery analysis and a targeted examination of proteomic biomarkers scrutinized by clinical validation. Methods Cerebrospinal fluid was obtained from PREDICT‐HD and
Daniel Chelsky   +8 more
wiley   +1 more source

HandyBroker - An intelligent product-brokering agent for M-commerce applications with user preference tracking [PDF]

open access: yes, 2002
One of the potential applications for agent-based systems is m-commerce. A lot of research has been done on making such systems intelligent to personalize their services for users.
Aylett   +14 more
core   +2 more sources

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin   +11 more
wiley   +1 more source

What impact will E-commerce have on the U.S. economy? [PDF]

open access: yes
In recent years, e-commerce has emerged as the fastest growing sector of the U.S. marketplace. Despite the contraction in the high-tech industry during the recent recession, firms have continued to enter and expand their presence in e-commerce, and ...
Jonathan L. Willis
core  

SAFE: Secure-Roaming Agents for E-commerce [PDF]

open access: yes, 2002
The development of the Internet has made a powerful impact on the concept of commerce. E-commerce, a new way to conduct business, is gaining more and more popularity.
Kotz, Sander, Sheng-Uei Guan, Yang Yang
core   +2 more sources

Variably Protease‐Sensitive Prionopathy: Two New Cases With Motor Neuron‐Dementia Syndrome

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT We describe two patients with variably protease‐sensitive prionopathy (VPSPr) who developed progressive upper motor neuron symptoms, insomnia, behavioral and cognitive decline, compatible with primary lateral sclerosis associated with frontotemporal dementia (FTD).
María Elena Erro   +10 more
wiley   +1 more source

Le commerce entre l’Italie et l’Orient entre xe et xiiie siècle : nouvelles polarités et reconfiguration des réseaux d’échanges

open access: yesCahiers d’Études Italiennes, 2017
It is usually admitted that the expansion of Italian merchants in Orient is the sole result of the political and economic power of Northern Italian cities and of the development of pre-capitalism in Europe.
Dominique Valérian
doaj   +1 more source

Electronic Commerce, Consumer Search and Retailing Cost Reduction [PDF]

open access: yes, 2001
This paper explains four things in a unified way. First, how e-commerce can generate price equilibria where physical shops either compete with virtual shops for consumers with Internet access, or alternatively, sell only to consumers with no Internet ...
Mazón, Cristina, Pereira, Pedro
core   +5 more sources

Home - About - Disclaimer - Privacy